Urogenital complaints and female sexual dysfunction (part 1)

Journal of Sexual Medicine

Volumn 7, Issue 5, 2010, Pages 1704-1713

  Wehbe, Salim A ^a   Whitmore, Kristene ^a   Kellogg Spadt, Susan ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Dyspareunia; Interstitial Cystitis; Overactive Bladder; Pelvic Floor Dysfunction; Sexual Dysfunction; Urinary Incontinence

Indexed keywords

AMITRIPTYLINE; BOTULINUM TOXIN A; BUPIVACAINE; CYCLOSPORIN A; DIAZEPAM; DIMETHYL SULFOXIDE; GABAPENTIN; HEPARIN; HYDROXYZINE; LIDOCAINE; MUSCARINIC RECEPTOR BLOCKING AGENT; PENTOSAN POLYSULFATE; PREGABALIN; SPASMOLYTIC AGENT; STEROID;

ARTICLE; BEHAVIOR THERAPY; CONSERVATIVE TREATMENT; COUNSELING; FEMALE; FEMALE SEXUAL DYSFUNCTION; HUMAN; HYPERSENSITIVITY; INTERSTITIAL CYSTITIS; LIFESTYLE MODIFICATION; MUSCLE HYPERTONIA; NEUROMODULATION; OVERACTIVE BLADDER; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; SEX THERAPY; URGE INCONTINENCE; CROSS-SECTIONAL STUDY; CYSTITIS, INTERSTITIAL; DYSPAREUNIA; FEMALE UROGENITAL DISEASES; PELVIS FLOOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

CROSS-SECTIONAL STUDIES; CYSTITIS, INTERSTITIAL; DYSPAREUNIA; FEMALE; FEMALE UROGENITAL DISEASES; HUMANS; MUSCLE HYPERTONIA; PELVIC FLOOR; QUALITY OF LIFE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 77953578929     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01769.x     Document Type: Article

References (80)

1. Hayes RD, Bennett CM, Fairley CK, Dennerstein L. What can prevalence studies tell us about female sexual difficulty and dysfunction? J Sex Med 2006, 3:589-95.
2. Bekker M, Beck J, Putter H, van Driel M, Pelger R, Lycklama À Nijeholt A, Elzevier H. The place of female sexual dysfunction in the urological practice:Results of a Dutch survey. J Sex Med 2009, 6:2979-87.
3. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, Goldstein I, Graziottin A, Heiman J, Laan E, Leiblum S, Padma-Nathan H, Rosen R, Segraves K, Segraves RT, Shabsigh R, Sipski M, Wagner G, Whipple B. Report of the international consensus of development conference on female sexual dysfunction: Definitions and classifications. J Urol 2000, 163:888-93.
4. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A. The standardization of terminology in lower urinary tract function. Report from the Standardization Sub-committee of the International Continence Society. Am J Obstet Gynecol 2002, 187:116-26.
5. Lukban JC, Whitmore KE. Pelvic floor muscle re-education: Treatment of the overactive bladder and painful bladder syndrome. Clin Obstet Gynecol 2000, 45:273-80.
6. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000, 26:191-208.
7. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999, 281:537-44.
8. Steege JF, Metzger DA, Levy BA. Chronic pelvic pain. An integrated approach 1998, Philadelphia, PA, W.B. Saunders Company
9. Goldwasser B. Urodynamics. Voiding function and dysfunction: A logical and practical approach 1988, 6. Wein AJBarrett DM. In, eds., Chicago, IL, Year Book Medical Publishers
10. Erickson DR, Morgan KC, Ordille S, Keay SK, Xie SX. Nonbladder related symptoms in patients with interstitial cystitis. J Urol 2001, 166:557-61.
11. Canavan TP, Heckman CD. Dyspareunia in women. Breaking the silence is the first step toward treatment. Postgrad Med 2000, 108:164-6.
12. Padmadas SS, Stones RW, Matthews Z. Dyspareunia and urinary sensory symptoms in India: Population-based study. J Sex Med 2006, 3:114-20.
13. Heim LJ. Evaluation and differential diagnosis of dyspareunia. Am Fam Physician 2001, 63:1535-44.
14. DeWitt DE. Dyspareunia. Tracing the cause. Postgrad Med 1991, 89:73-8.
15. Steege JF, Ling FW. Dyspareunia. A special type of chronic pelvic pain. Obstet Gynecol Clin North Am 1993, 20:779-93.
16. Leppilahti M, Sairanen J, Tammela TL, Aaltomaa S, Lehtoranta K, Auvinen A. Prevalence of clinically confirmed interstitial cystitis in women: A population based study in Finland. J Urol 2005, 174:581-3. Finnish Interstitial Cystitis-Pelvic Pain Syndrome Study Group
17. Berry SH, Stoto MA, Elliott M, Suttorp M, Bogart L, Eggers PW, Leroy M, Nyberg LM, Clemens JQ. Prevalence of interstitial cystitis/painful bladder syndrome in the United States. The Rand Interstitial Cystitis Epidemiology (RICE) study. May 2009 Annual Meeting of the American Urological Association, Chicago IL. [moderated poster
18. Metts JF. Interstitial cystitis: Urgency and frequency syndrome. Am Fam Physician 2001, 64:1199-206.
19. Rosenberg MT, Page S, Hazzard MA. Prevalence of interstitial cystitis in a primary care setting. Urology 2007, 69:48-52.
20. Parsons CL, Dell J, Stanford EJ, Bullen M, Kahn BS, Waxell T, Koziol JA. Increased prevalence of interstitial cystitis: Previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology 2002, 60:573-8.
21. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on interstitial cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 1988, 140:203-6.
22. Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L. The diagnosis of interstitial cystitis revisited: Lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol 1999, 161:553-7.
23. Evans RJ. Treatment approaches for interstitial cystitis: Multimodality therapy. Rev Urol 2002, 4:S16-20.
24. Nickel JC. Interstitial cystitis-An elusive clinical target? J Urol 2003, 170:816-7.
25. Driscoll A, Teichman JM. How do patients with interstitial cystitis present? J Urol 2001, 166:2118-20.
26. Porru D, Politanò R, Gerardini M, Giliberto GL, Stancati S, Pasini L, Tinelli C, Rovereto B. Different clinical presentation of interstitial cystitis syndrome. Int Urogynecol J Pelvic Floor Dysfunct 2004, 15:198-202.
27. Dell JR. Chronic pelvic pain of bladder origin: A focus on interstitial cystitis. Int J Fertil Womens Med 2003, 48:154-62.
28. Webster DC, Brennan T. Use and effectiveness of sexual self-care strategies for interstitial cystitis. Urol Nurs 1995, 15:14-22.
29. Kellogg-Spadt S, Whitmore KE. Role of the female urologist/urogynecologist. Women's sexual function and dysfunction: Study, diagnosis and treatment 2006, 17:708-14. Goldstein I, Meston CMDavis SRTraish AM. In, eds., Vol, London, Taylor and Francis
30. Koziol JA. Epidemiology of interstitial cystitis. Urol Clin North Am 1994, 21:7-20.
31. Webster DC. Recontextualizing sexuality in chronic illness: Women and interstitial cystitis. Health Care Women Int 1997, 18:575-89.
32. Butrick CW. Interstitial cystitis and chronic pelvic pain: New insights in neuropathology, diagnosis, and treatment. Clin Obstet Gynecol 2003, 46:811-23.
33. Nickel JC, Tripp D, Teal V, Propert KJ, Burks D, Foster HE, Hanno P, Mayer R, Payne CK, Peters KM, Kusek JW, Nyberg LM. Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis. J Urol 2007, 177:1832-6. Interstitial Cystitis Collaborative Trials Group
34. Tincello DG, Walker AC. Interstitial cystitis in the UK: Results of a questionnaire survey of members of the Interstitial Cystitis Support Group. Eur J Obstet Gynecol Reprod Biol 2005, 118:91-5.
35. Zaslau S, Riggs DR, Perlmutter AE, Jackson BJ, Osborne J, Kandzari SJ. Sexual dysfunction in patients with painful bladder syndrome is age related and progressive. Can J Urol 2008, 15:4158-62.
36. Peters KM, Killinger KA, Carrico DJ, Ibrahim IA, Diokno AC, Graziottin A. Sexual function and sexual distress in women with interstitial cystitis: A case-control study. Urology 2007, 70:543-7.
37. Ottem DP, Carr LK, Perks AE, Lee P, Teichman JM. Interstitial cystitis and female sexual dysfunction. Urology 2007, 69:608-10.
38. Graziottin A. Sexual pain disorders: Dyspareunia and vaginismus. Standard practice in sexual medicine 2006, 342-50. Porst HBuvat J. In, The Standards Committee of the International Society for Sexual Medicine, eds., Oxford, Blackwell
39. Myers DL, Aguilar VC. Gynecologic manifestations of interstitial cystitis. Clin Obstet Gynecol 2002, 45:233-41.
40. Whitmore KE. Self-care regimens for patients with interstitial cystitis. Urol Clin North Am 1994, 21:121-30.
41. Dell JR, Parsons CL. Multimodal therapy for interstitial cystitis. J Reprod Med 2004, 49:243-52.
42. Alagiri M, Chottiner S, Ratner V, Slade D, Hanno PM. Interstitial cystitis: Unexplained associations with other chronic disease and pain syndromes. Urology 1997, 49:52-7.
43. Kirkemo A, Peabody M, Diokno AC, Afanasyev A, Nyberg LM, Landis JR, Cook YL, Simon LJ. Associations among urodynamic findings and symptoms in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology 1997, 49:76-7.
44. Bade JJ, Peters JM, Mensink HJ. Is the diet of patients with interstitial cystitis related to their disease? Eur Urol 1997, 32:179-83.
45. Brookoff D. The causes and treatment of pain in interstitial cystitis. Interstitial cystitis 1997, Sant GR. In, ed., Philadelphia, PA, Raven-Lippincott
46. Comiter CV. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: A prospective study. J Urol 2003, 161:1369-73.
47. Travell J, Simons DG. Myofascial pain and dysfunction: The trigger point manual, vol. 2, the lower extremities 1998, Baltimore, MD, Williams and Wilkins
48. Whitmore K, Kellogg-Spadt S, Fletcher E. Comprehensive assessment of the pelvic floor. Issues Incontinence 1998, Fall:1-10.
49. Moldwin RM. Similarities between interstitial cystitis and male chronic pelvic pain syndrome. Curr Urol Rep 2002, 3:313-8.
50. Thiele GH. Coccygodynia and pain in the superior gluteal region. JAMA 1937, 109:1271-5.
51. Fitzgerald MP, Kotarinos R. Rehabilitation of the short pelvic floor. II: Treatment of the patient with the short pelvic floor. Int Urogynecol J Pelvic Floor Dysfunct 2003, 14:269-75.
52. Thiele GH. Coccygodynia: Cause and treatment. Dis Colon Rectum 1963, 6:422-36.
53. Weiss JM. Pelvic floor myofascial trigger points: Manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol 2001, 166:2226-31.
54. Oyama IA, Rejba A, Lukban JC, Fletcher E, Kellogg-Spadt S, Holzberg AS, Whitmore KE. Modified Thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urology 2004, 64:862-5.
55. FitzGerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, Kotarinos R, Fraser L, Cosby A, Fortman C, Neville C, Badillo S, Odabachian L, Sanfield A, O'Dougherty B, Halle-Podell R, Cen L, Chuai S, Landis JR, Mickelberg K, Barrell T, Kusek JW, Nyberg LM. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol 2009, 182:570-80. Urological Pelvic Pain Collaborative Research Network
56. Rogalski MJ, Kellogg-Spadt S, Rejba A, Fariello J, Whitmore KE. Retrospective review of vaginal diazepam suppository use in high tone pelvic floor dysfunction. Poster presentation, 30th Annual Meeting of the American Urogynecologic Society, Hollywood, FL, September 24-26, 2009
57. Langford CF, Udvari Nagy S, Ghoniem GM. Levator ani trigger point injections: An underutilized treatment for chronic pelvic pain. Neurourol Urodyn 2007, 26:59-62.
58. Romito S, Bottanelli M, Pellegrini M, Vicentini S, Rizzuto N, Bertolasi L. Botulinum toxin for the treatment of genital pain syndromes. Gynecol Obstet Invest 2004, 58:164-7.
59. Jarvis SK, Abbott JA, Lenart MB, Steensma A, Vancaillie TG. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Aust N Z J Obstet Gynaecol 2004, 44:46-50.
60. Thomson AJ, Jarvis SK, Lenart M, Abbott JA, Vancaillie TG. The use of botulinum toxin type A (BOTOX) as treatment for intractable chronic pelvic pain associated with spasm of the levator ani muscles. BJOG 2005, 112:247-9.
61. Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: A randomized controlled trial. Obstet Gynecol 2006, 108:915-23.
62. Rao SS, Paulson J, Mata M, Zimmerman B. Clinical trial: Effects of botulinum toxin on Levator ani syndrome-a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2009, 29:985-91.
63. Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population based prevalence study. BJU Int 2001, 87:760-6.
64. Berglund A, Eisemann M, Lalos A. Social adjustment and spouse relationships among women with stress incontinence before and after surgical treatment. Soc Sci Med 1996, 42:1537-44.
65. Berglund A, Fugl-Meyer K. Some sexological characteristics of stress incontinent women. Scand J Urol Nephrol 1996, 30:207-312.
66. Roe B, May C. Incontinence and sexuality: Findings from a qualitative prospective. J Adv Nurs 1999, 30:573-9.
67. Weber A, Walters M, Peidmonte M. Sexual function and vaginal anatomy in women before and after surgery for pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol 2000, 182:1610-5.
68. Aslan G, Köseoglu H, Sadik O, Gimen S, Cihan A, Esen A. Sexual function in women with urinary incontinence. Int J Impot Res 2005, 17:248-51.
69. Salonia A, Zanni G, Nappi RE, Briganti A, Dehò F, Fabbri F, Colombo R, Guazzoni G, Di Girolamo V, Rigatti P, Montorsi F. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study. Eur Urol 2004, 45:642-8.
70. Urwitz-Lane R, Ozel B. Sexual function in women with urodynamic stress incontinence, detrusor overactivity, and mixed urinary incontinence. Am J Obstet Gynecol 2006, 195:1758-61.
71. Handa VL, Harvey L, Cundiff GW, Siddique SA, Kjerulff KH. Sexual function among women with urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 2004, 191:751-6.
72. Coyne KS, Margolis MK, Jumadilova Z, Bavendam T, Mueller E, Rogers R. Overactive bladder and women's sexual health: What is the impact? J Sex Med 2007, 4:656-66.
73. Cohen BL, Barboglio P, Gousse A. The impact of lower urinary tract symptoms and urinary incontinence on female sexual dysfunction using a validated instrument. J Sex Med 2008, 5:1418-23.
74. Jha S, Radley S, Farkas A, Jones G. The impact of TVT on sexual function. Int Urogynecol J Pelvic Floor Dysfunct 2008, 20:165-9.
75. Oh SJ, Choo MS, Kim HS, Kim JC, Lee JG, Yun JM, Kim DY, Paick JS, Lee JY, Chung BS, Min KS, Kim YH, Jung HC, Son H, Jeong JY, Rho J, Lee KS, Park WH, Ku JH. Generic and disease-specific health-related quality of life in women with coital incontinence: A prospective, multicenter study. Gynecol Obstet Invest 2008, 65:62-7.
76. Kim YH, Seo JT, Yoon H. The effect of overactive bladder syndrome on the sexual quality of life in Korean young and middle aged women. Int J Impot Res 2005, 17:158-63.
77. Espuña PM, Clota PM. Coital urinary incontinence: Impact on quality of life as measured by the King's Health Questionnaire. Int Urogynecol J Pelvic Floor Dysfunct 2008, 19:621-5.
78. Serati M, Salvatore S, Uccella S, Nappi RE, Bolis P. Female urinary incontinence during intercourse: A review on an understudied problem for women's sexuality. J Sex Med 2009, 6:40-8.
79. Parker WH, Rosenman AE, Parker R. The incontinence solution 2002, 940-110. New York, Simon and Schuster
80. Glazener CMA, Herbison GP, Wilson PD. Conservative management of persistent postnatal urinary and faecal incontinence: Randomised controlled trial. BMJ 2001, 323:593-6.